EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Uncovering novel germline variants associated with testicular germ cell tumors by exome sequencing

Berenice Cuevas-Estrada iD, Juan A Ríos-Rodríguez iD, José A García-Pacheco iD, Talia Wegman-Ostrosky iD, Alejandra Cervera iD, Nicolas Alcaraz iD, Michel Montalvo-Casimiro iD, Alejandra Barrón-Hernández iD, Clementina Castro-Hernández iD, Miguel A Jiménez-Ríos iD, Nora Sobrevilla-Moreno iD, Cristian Arriaga-Canon iD und 2 weitere

NAR Cancer · 08.04.2026 · 8 (2)

DOI: 10.1093/narcan/zcag007 ↗

Kurz gefasst

Fachartikel in der Zeitschrift NAR Cancer, online erschienen am 20.04.2026. Verfasst von Berenice Cuevas-Estrada und 13 weiteren Autor:innen. Beteiligte Einrichtung: Laboratorio de Regulación de la Cromatina y Genómica, Instituto Nacional de Cancerología,Mexico City 14080,Mexico. Hauptthemen laut MEDLINE: Neoplasms, Germ Cell and Embryonal, Testicular Neoplasms, Genetic Predisposition to Disease, Exome Sequencing. Die Arbeit nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Instituto Nacional de Cancerología, Consejo Nacional de Humanidades, Ciencias y Tecnologías.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Testicular germ cell tumors (TGCT) are highly heritable malignancies that display increasing incidence worldwide, with rising mortality rates particularly evident among Hispanic men. However, genomic studies of TGCT have largely focused on European cohorts, limiting accurate risk prediction in other populations. We investigated rare germline variants contributing to TGCT susceptibility in a Hispanic cohort. Exome sequencing data (mean depth 60x) from 40 Mexican TGCT patients were analyzed against two ancestry-matched control groups using gene-based aggregation analyses and single-variant association. Top candidate variants were validated and replicated in an independent cohort of 211 TGCT patients, with Mexican individuals from the PAGE study serving as a third control group. Gene-based testing revealed seven genes, including MAP3K5, VAV2, and CAPN8, with nominal associations. Three previously unreported variants: rs2273499 in ARFGAP1 (OR 3.72), rs147153778 in SLCO4A1 (OR 2.21), and rs79783591 in MC4R (OR 2.31), showed statistically significant results and consistent directionality in the replication cohort, representing suggestive TGCT risk variants that warrant further validation, although none reached exome-wide significance. All three also displayed preliminary associations with mortality, indicating potential prognostic relevance. These findings provide exploratory, population-enriched signals of genetic susceptibility to TGCT in Hispanics. Altogether, they emphasize the critical need for more inclusive genomic research in underrepresented populations and provide a foundation for future investigations aimed at improving population-tailored risk assessment and prognostic tools.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neoplasms, Germ Cell and EmbryonalTesticular NeoplasmsGenetic Predisposition to DiseaseExome SequencingGerm-Line MutationHumansMalePolymorphism, Single NucleotideAdultExome

Autor:innen und Institutionen

  • Laboratorio de Regulación de la Cromatina y Genómica, Instituto Nacional de Cancerología,Mexico City 14080,Mexico.
  • Escuela de Medicina y Ciencias de la Salud, Tecnológico de Monterrey,Ciudad de México 14380,México.
  • Precision Medicine Laboratory, Sub-Direction of Research Unit, Instituto Nacional de Cancerología, Mexico City 14080,Mexico.
  • Laboratorio de Genómica Biomédica y Bioinformática, Instituto Nacional de Medicina Genómica (INMEGEN),Mexico City 14610,Mexico.
  • Center for Epigenetic Cell Memory, Danish Cancer Institute, Danish Cancer Society,Copenhagen 2100,Denmark.
  • Department of Cellular and Molecular Medicine, Novo Nordisk Foundation Center for Protein Research, University of Copenhagen,Copenhagen 2200,Denmark.

ORCID-Profile: Berenice Cuevas-Estrada, Juan A Ríos-Rodríguez, José A García-Pacheco, Talia Wegman-Ostrosky, Alejandra Cervera, Nicolas Alcaraz, Michel Montalvo-Casimiro, Alejandra Barrón-Hernández, Clementina Castro-Hernández, Miguel A Jiménez-Ríos, Nora Sobrevilla-Moreno, Cristian Arriaga-Canon, Luis A Herrera, Rodrigo González-Barrios

Förderung

  • Instituto Nacional de Cancerología
  • Consejo Nacional de Humanidades
  • Ciencias y Tecnologías
  • Financiamiento de Proyectos de Investigación para la Salud
  • Dirección General de Políticas de Investigación en Salud
  • Secretaría de Salud, México

Zitieren

APA

Cuevas-Estrada, B., Ríos-Rodríguez, J. A., García-Pacheco, J. A., Wegman-Ostrosky, T., Cervera, A., Alcaraz, N., Montalvo-Casimiro, M., Barrón-Hernández, A., Castro-Hernández, C., Jiménez-Ríos, M. A., Sobrevilla-Moreno, N., Arriaga-Canon, C., Herrera, L. A., & González-Barrios, R. (2026). Uncovering novel germline variants associated with testicular germ cell tumors by exome sequencing. NAR Cancer, 8(2). https://doi.org/10.1093/narcan/zcag007

Vancouver

Cuevas-Estrada B, Ríos-Rodríguez JA, García-Pacheco JA, Wegman-Ostrosky T, Cervera A, Alcaraz N, et al. Uncovering novel germline variants associated with testicular germ cell tumors by exome sequencing. NAR Cancer. 2026;8(2). doi:10.1093/narcan/zcag007

BibTeX
@article{CuevasEstrada2026,
  author = {Cuevas-Estrada, Berenice and Ríos-Rodríguez, Juan A and García-Pacheco, José A and Wegman-Ostrosky, Talia and Cervera, Alejandra and Alcaraz, Nicolas and Montalvo-Casimiro, Michel and Barrón-Hernández, Alejandra and Castro-Hernández, Clementina and Jiménez-Ríos, Miguel A and Sobrevilla-Moreno, Nora and Arriaga-Canon, Cristian and Herrera, Luis A and González-Barrios, Rodrigo},
  title = {Uncovering novel germline variants associated with testicular germ cell tumors by exome sequencing},
  journal = {NAR Cancer},
  year = {2026},
  volume = {8},
  number = {2},
  doi = {10.1093/narcan/zcag007}
}
Kostenlos starten →